Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-008605
Filing Date
2024-12-30
Accepted
2024-12-30 07:54:56
Documents
1
Period of Report
2024-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 1989
  Complete submission text file 0001562180-24-008605.txt   3487
Mailing Address C/O BROOKSIDE CAPITAL, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST BOSTON MA 02116
Business Address
Koppel Adam (Reporting) CIK: 0001578965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39634 | Film No.: 241586964

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)